Everhart Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Sell
5,246
-774
-13% -$62.4K 0.03% 304
2026
Q1
$522K Buy
6,020
+655
+12% +$62.7K 0.04% 265
2025
Q4
$515K Buy
5,365
+565
+12% +$54.9K 0.05% 256
2025
Q3
$457K Buy
4,800
+1,415
+42% +$130K 0.05% 264
2025
Q2
$295K Buy
3,385
+418
+14% +$35.4K 0.03% 289
2025
Q1
$267K Buy
+2,967
New +$265K 0.04% 288

Other funds holding MDT

Everhart Financial Group's MDT Position: Q2 2026 in Review

Everhart Financial Group reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $62.4K and leaving 5,246 shares worth $410K. The position accounts for 0.03% of the portfolio, ranked #304.

Everhart Financial Group first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $522K in Q1 2026. 535 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Everhart Financial Group held 5,246 shares of Medtronic worth $410K as of Q2 2026.
  • Everhart Financial Group sold 774 Medtronic shares in Q2 2026, an estimated $62.4K.
  • Medtronic made up 0.03% of Everhart Financial Group's portfolio in Q2 2026, its #304 holding.
  • Everhart Financial Group first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • Everhart Financial Group's Medtronic position peaked at $522K in Q1 2026.
  • 535 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.